Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-224 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of AD-224 for essential hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• AD-224

Snippet

Sponsor: Addpharma Inc. | Conditions: Hypertension,Essential | Phase 3 | Status: RECRUITING